<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Acadia Pharmaceuticals Inc. | Company News & Executive Profiles - ACAD | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/acadia+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Acadia Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="10" found="17" />
	<language>en-us</language>
	<item>
		<title><![CDATA[ACADIA Pharmaceuticals, Inc. Q3 2009 Earnings Conference Call]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-363099.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions. Our first question comes from the line of Charles Duncan from JPM Securities. Please proceed. Charles Duncan - JPM Securities I had a question regarding the schizophrenia disease and adjunctive therapy trial you mentioned Uli that that might be the quickest route to the market,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 09 Nov 2009 16:29:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/acadia+pharmaceuticals+inc..html"><![CDATA[Acadia Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/trial.html"><![CDATA[Trial]]></category>
		<category domain="http://resources.bnet.com/topic/automatic+data+processing+inc..html"><![CDATA[Automatic Data Processing Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/payroll+solutions.html"><![CDATA[Payroll Solutions]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACAD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADP</category>
		<category domain="tickers">ACAD,ADP</category>
	</item>
	<item>
		<title><![CDATA[Take Advantage of Biovail Weakness - RBC]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F159605-take-advantage-of-biovail-weakness-rbc%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[FP Trading Desk submits:  Investors should take advantage of Biovail Corp.'s BVF falling stock price on Tuesday, says Douglas Miehm, RBC Capital Markets analyst.  Shares in the Canadian pharmaceutical company fell almost 2% or 25¢ to C$13.74 on Tuesday after the company announced a failed trial of a...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 02 Sep 2009 06:07:05 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/fp+trading+desk.html"><![CDATA[FP Trading Desk]]></category>
		<category domain="http://resources.bnet.com/topic/acadia+pharmaceuticals+inc..html"><![CDATA[Acadia Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biovail+corp..html"><![CDATA[Biovail Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACAD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVF</category>
		<category domain="tickers">ACAD,BVF</category>
	</item>
	<item>
		<title><![CDATA[Acadia Offers Opportunity]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F137386-acadia-offers-opportunity%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:    By Jason Napodano, CFA Acadia Pharmaceuticals&#8217; ACAD stock continues to trade below cash value despite the recent positive collaboration on pimavanserin with Biovail BVF. Besides Biovail, Acadia has new relationship with the Michael J. Fox Foundation and Meiji Seika Kaisha, Ltd, as well as an...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 13 May 2009 02:58:57 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/acadia+pharmaceuticals+inc..html"><![CDATA[Acadia Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACAD</category>
		<category domain="tickers">ACAD</category>
	</item>
	<item>
		<title><![CDATA[Biovail 'Still Not Getting the Attention It Deserves' - UBS]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F135387-biovail-still-not-getting-the-attention-it-deserves-ubs%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[FP Trading Desk submits:  Biovail Corp.'s BVF latest rights acquisition is right on strategy, but whether it proves profitable will likely remain unknown for some time to come, says UBS analyst Marc Goodman. On Monday, Biovail entered into an agreement with Acadia Pharmaceuticals Inc. ACAD, to co-develop Acadia's experimental...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 05 May 2009 10:39:22 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/fp+trading+desk.html"><![CDATA[FP Trading Desk]]></category>
		<category domain="http://resources.bnet.com/topic/acadia+pharmaceuticals+inc..html"><![CDATA[Acadia Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biovail+corp..html"><![CDATA[Biovail Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACAD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVF</category>
		<category domain="tickers">ACAD,BVF</category>
	</item>
	<item>
		<title><![CDATA[Acadia Pharmaceuticals, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-277261.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions.  Your first question comes from Charles Duncan with JMP. Charles Duncan &#8211; JMP  I had a quick question for Roger.  Can you run through your assumptions in terms of powering for the primary efficacy endpoint?  You said 90%, I believe,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 09 Mar 2009 18:08:34 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/acadia+pharmaceuticals+inc..html"><![CDATA[Acadia Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/study.html"><![CDATA[Study]]></category>
		<category domain="http://resources.bnet.com/topic/variability.html"><![CDATA[Variability]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACAD</category>
		<category domain="tickers">ACAD</category>
	</item>
	<item>
		<title><![CDATA[ACADIA Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-246737.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions Your first question comes from the line of William Ho - Banc Of America Securities. William Ho - Banc Of America Securities I guess, first of all, I am just wondering can you provide us or just discuss the approximate cost of completing the...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 05 Nov 2008 18:40:33 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/specificity.html"><![CDATA[Specificity]]></category>
		<category domain="http://resources.bnet.com/topic/acadia+pharmaceuticals+inc..html"><![CDATA[Acadia Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/banc+of+america+securities.html"><![CDATA[Banc Of America Securities]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/pimavanserin.html"><![CDATA[Pimavanserin]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/specificity.html"><![CDATA[Specificity]]></category>
		<category domain="http://resources.bnet.com/topic/acadia+pharmaceuticals+inc..html"><![CDATA[Acadia Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/banc+of+america+securities.html"><![CDATA[Banc Of America Securities]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/pimavanserin.html"><![CDATA[Pimavanserin]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACAD</category>
		<category domain="tickers">ACAD</category>
	</item>
	<item>
		<title><![CDATA[Zacks Analyst Blog Highlights: AutoNation, Inc., Oscient Pharmaceuticals Corp., Equity Residential, ACADIA Pharmaceuticals Inc. and Allergan, Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_3/ai_n29474534]]></link>
		<description><![CDATA[CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: AutoNation, Inc. (NYSE: AN), Oscient Pharmaceuticals Corp. (Nasdaq: OSCI), Equity Residential...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 03 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/acadia+pharmaceuticals+inc..html"><![CDATA[Acadia Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/allergan+inc..html"><![CDATA[Allergan Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/analyst.html"><![CDATA[analyst]]></category>
		<category domain="http://resources.bnet.com/topic/autonation+inc..html"><![CDATA[AutoNation Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/blog.html"><![CDATA[blog]]></category>
		<category domain="http://resources.bnet.com/topic/equity+residential.html"><![CDATA[Equity Residential]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/oscient+pharmaceuticals+corp..html"><![CDATA[Oscient Pharmaceuticals Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACAD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EQR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
		<category domain="tickers">ACAD,AGN,AN,EQR,NDAQ,OSCI</category>
	</item>
	<item>
		<title><![CDATA[Analyst Reports for Electronic Arts Inc., Teva Pharmaceutical Industries Limited, ACADIA Pharmaceuticals Inc., and Sport Supply Group Inc.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200809/ai_n28054267]]></link>
		<description><![CDATA[MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for Electronic...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 03 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/acadia+pharmaceuticals+inc..html"><![CDATA[Acadia Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/analyst.html"><![CDATA[analyst]]></category>
		<category domain="http://resources.bnet.com/topic/electronic+arts+inc..html"><![CDATA[Electronic Arts Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sport+supply+group+inc..html"><![CDATA[Sport Supply Group Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACAD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ERTS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RBI</category>
		<category domain="tickers">ACAD,ERTS,NDAQ,RBI</category>
	</item>
	<item>
		<title><![CDATA[ACADIA Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-227438.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions.  Your first question comes from the line of Jim Birchenough with Lehman Brothers.  Please proceed. Jim Birchenough Hi guys, a couple of questions.  I know you don&#8217;t want to provide any timelines or detail around partnership discussions.  I am just wondering...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 05 May 2008 17:08:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/acadia+pharmaceuticals+inc..html"><![CDATA[Acadia Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACAD</category>
		<category domain="tickers">ACAD</category>
	</item>
	<item>
		<title><![CDATA[ACADIA Pharmaceuticals to Present at the 8th Annual Fortis Bank Biotechnology Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_28/ai_n24961594]]></link>
		<description><![CDATA[SAN DIEGO -- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at The 8th Annual Fortis Bank Biotechnology Conference on Thursday, April 3, 2008, at 10:00...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 28 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/acadia+pharmaceuticals+inc..html"><![CDATA[Acadia Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/fortis+n.v..html"><![CDATA[Fortis N.V.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACAD</category>
		<category domain="tickers">ACAD</category>
	</item>
</channel>
</rss>
